StocksMedium•5 October 2026•
1 min read
Insmed Announces CFO Transition and Reaffirms Full-Year 2026 Guidance
Key Facts
1Sara Bonstein will step down as CFO of Insmed on October 30, 2026, after nearly seven years in the role.
2The company reaffirmed its full-year 2026 financial guidance.
3The third-quarter 2026 financial results conference call is scheduled for October 29, 2026.
Insmed announced that Sara Bonstein will step down as Chief Financial Officer on October 30, 2026, following nearly seven years in the position. According to a statement released via PR Newswire, the company reaffirmed its full-year 2026 financial guidance alongside the leadership transition. The company has scheduled its third-quarter 2026 financial results conference call for October 29, 2026.
INSM closed at $111.12 on October 2, 2026, with the stock reaching a session high of $111.54 and a low of $105.68. The executive transition is timed to occur one day after the scheduled quarterly earnings call, as the firm maintains its qualitative growth outlook for the remainder of the fiscal year.